Exosome Research Market - Global Industry Size, Share, Trends, Opportunities, and Forecast, 2018-2028, Segmented by Product (Kits and Reagents, Instruments, and Other Products), By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, and Others), By Application (Biomarkers, Vaccine Development, Tissue Regeneration, and Other Applications), By Region and Competition

Industry : Healthcare
Pages : NA
Published Date : NA

Customization Enquiry

Buy Now

Single User Licence

$4900

Multi-User Licence

$5900

Custom Research Licence

$8900

Summary

Request Sample

Report Description

Exosome research market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the surge in the funding for research and development activities along with the increasing prevalence of cancer along with increasing interest in exosome-based procedures. Also, ongoing advances in exosome technology in drug development and discovery are expected to create lucrative growth during the forecast period. Similarly, the increasing demand for drug therapies and a surge in research and development activities in the pharmaceutical industry is the major factor driving the growth of the market over the years. According to the GLOBOCAN 2020 report, 19.29 million people are living with cancer, and this number is expected to rise over the next two decades across the world. With the rising number of cancer cases, it is believed that the application of exosomes in coping with cancer would be high, which is expected to contribute to market growth.

Increase in Research Funding

The increase in research funding has been a significant driver of growth in the global exosome research market. This funding has enabled researchers to conduct more extensive and in-depth studies on exosomes, leading to a greater understanding of their biology and potential clinical applications. Increased funding for exosome research has allowed for the development of new technologies and methodologies for the isolation, analysis, and characterization of exosomes. This has led to the creation of new products and services in the exosome research market and new diagnostic and therapeutic applications for exosomes. With greater funding comes the ability to expand the scope of research into exosomes. This has allowed researchers to explore new areas of exosome biology and investigate their potential roles in a wider range of diseases and conditions. This expanded research scope has led to a greater understanding of the clinical applications of exosomes and has driven growth in the exosome research market.

Increased research funding has made exosome research a more attractive area for investment, leading to the creation of new companies and products in the exosome research market. This investment has helped to drive innovation and accelerate the development of exosome-based therapies and diagnostics. Several companies have recently expanded their pipelines to include exosome-based therapies. For example, Codiak Biosciences has entered into a collaboration with Jazz Pharmaceuticals to develop exosome-based therapies for the treatment of cancer. The development of new and improved exosome isolation technologies has been a key area of focus in the exosome research market. Recent advancements in this area include the use of microfluidic devices for high-throughput exosome isolation and the development of new methods for the isolation of exosomes from specific cell types.

Advances in Exosome Isolation and Analysis Technologies

Advances in exosome isolation and analysis technologies have had a significant impact on the global exosome research market. These advances have made it easier and more efficient for researchers to study exosomes, leading to a better understanding of their biology and potential clinical applications. Advances in exosome isolation and analysis technologies have led to improvements in accuracy and efficiency, allowing researchers to obtain high-quality exosome samples and analyze them more quickly and accurately. This has helped to accelerate research and development in the exosome research market. New technologies have been developed that allow the detection and analysis of smaller amounts of exosomes, increasing the sensitivity of exosome-based assays and leading to more precise results. This has opened up new avenues of research and led to the development of new products and services in the exosome research market.

Advances in exosome isolation and analysis technologies have led to the development of new products and services in the exosome research market, including kits for exosome isolation and analysis, exosome-based diagnostics, and exosome-based therapeutics. These products and services have driven growth in the exosome research market and created new opportunities for companies operating in this space. The improved accuracy and sensitivity of exosome isolation and analysis technologies have led to a better understanding of exosome biology and its role in various diseases and conditions. This increased understanding has driven the development of new diagnostic and therapeutic applications for exosomes, which has further contributed to the growth of the exosome research market.

Growing Awareness of Potential Clinical Applications of Exosomes

The growing awareness of the potential clinical applications of exosomes has had a significant impact on the global exosome research market. As researchers and clinicians have become more aware of the unique properties and functions of exosomes, interest in their potential therapeutic and diagnostic applications has grown. As awareness of the potential clinical applications of exosomes has grown, investment in the development of exosome-based therapeutics and diagnostics has increased. This has led to the creation of new companies and products in the exosome research market, driving growth and innovation. The potential clinical applications of exosomes include the treatment of a wide range of diseases and conditions, including cancer, neurological disorders, and cardiovascular diseases.

As awareness of this potential has grown, researchers have focused on developing exosome-based therapies, leading to the creation of new products and services in the exosome research market. Exosomes have also shown promise as biomarkers for the diagnosis of various diseases and conditions. Growing awareness about this potential has led to the development of new exosome-based diagnostic tests, which have driven the exosome research market. As exosome-based therapies and diagnostics have moved closer to clinical use, regulatory agencies have become increasingly involved in the development and approval process. Growing awareness of the potential clinical applications of exosomes has led to increased regulatory scrutiny, which has helped to ensure the safety and efficacy of exosome-based products and services.

Increasing Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases is impacting the global exosome research market substantially. Chronic diseases, such as cancer, cardiovascular disease, and neurological disorders, are major public health challenges, affecting millions of people worldwide. Exosomes have shown promise as potential diagnostic and therapeutic tools for these and other chronic diseases, driving growth in the exosome research market.

The rise in chronic diseases has led to a growing focus on research, creating an opportunity for the potential role of exosomes in disease diagnosis, treatment, and monitoring. Researchers' search for exosomes' potential as biomarkers and therapeutics is aiding the market’s growth. Exosomes have shown promise as a novel class of therapeutics, capable of delivering drugs and genetic material to specific cells and tissues.

The demand for new treatments has also been on the rise due to the rising prevalence of chronic diseases, driving the development of exosome-based therapies and products.

Exosomes have also shown promise as diagnostic tools for various chronic diseases. By analyzing exosomes present in bodily fluids, researchers can identify biomarkers that may indicate the presence of disease. This has driven the development of new exosome-based diagnostic tests and tools, leading to an expansion in the exosome research market. The increasing prevalence of chronic diseases has created a significant market demand for new and effective therapies and diagnostic tools. As exosomes have shown promise as a potential solution to these challenges, the exosome research market has grown in response to this demand.

Recent Developments

EV Shuttle™ Exosome Isolation Kit (System Biosciences LLC, 2021): This exosome isolation kit is designed for the isolation of high-quality exosomes from a variety of sample types, including serum, plasma, and cell culture supernatant.

ExoLution™ Plus (BioVision Inc., 2020): This exosome isolation kit is designed for the isolation of high-purity exosomes from a variety of biological fluids, including blood, urine, and saliva. The kit is based on a precipitation method and can isolate exosomes from both small and large volumes of samples.

ExoTest™ Prostate (NanoView Biosciences Inc., 2019): This exosome-based diagnostic test is designed to detect prostate cancer using a small amount of urine. The test is based on the detection of exosomes containing specific biomarkers that are associated with prostate cancer.

EV-TRACK (The International Society for Extracellular Vesicles, 2019): This online resource provides a standardized reporting framework for studies involving extracellular vesicles, including exosomes. The resource includes a checklist of recommended information to be reported in publications, as well as a database of published studies that meet the reporting standards.

ExoCarta (Johns Hopkins University, 2018): This database provides a comprehensive collection of exosome-related data, including information on exosome proteins, RNA, and lipids. The database is freely available and can be used for research on exosome biology and potential applications.

Download Free Sample Report

Market Segmentation

The global exosome research market can be segmented by product, indication, application, and region. Based on the product, the market can be segmented into kits and reagents, instruments, and other products. Based on indication, the market can be differentiated into cancer, neurodegenerative diseases, cardiovascular diseases, infectious diseases, and others. Based on application, the market can be grouped into biomarkers, vaccine development, tissue regeneration, and other applications.

Market Players

Thermo Fisher Scientific., System Biosciences., Bio-Techne., Lonza., QIAGEN., ExoDx., Hitachi Chemical., Aethlon Medical., NanoSomiX., Malvern Panalytical., Sistemic Scotland Limited, and NX PharmaGen are some of the leading players operating in the global exosome research market.

Attribute	Details
Base Year	2022
Historic Data	2018 – 2021
Estimated Year	2023
Forecast Period	2024 – 2028
Quantitative Units	Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
Report Coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments Covered	By Product By Indication By Application By Region
Regional Scope	North America; Europe; Asia Pacific; South America; Middle East & Africa
Country Scope	United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE
Key Companies Profiled	Thermo Fisher Scientific., System Biosciences., Bio-Techne., Lonza., QIAGEN., ExoDx., Hitachi Chemical., Aethlon Medical., NanoSomiX., Malvern Panalytical., Sistemic Scotland Limited, NX PharmaGen
Customization Scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, the global exosome research market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Exosome Research Market, By Product:

o Kits and Reagents

o Instruments

o Other Products

· Exosome Research Market, By Indication:

o Cancer

o Neurodegenerative diseases

o Cardiovascular diseases

o Infectious diseases

o Others

· Exosome Research Market, By Application:

o Biomarkers

o Vaccine Development

o Tissue Regeneration

o Other Applications

· Exosome Research Market, By Region:

North America

United States
Canada
Mexico

Europe

France
Germany
United Kingdom
Italy
Spain

Asia Pacific

China
India
Japan
South Korea
Australia

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Exosome Research Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

The global exosome research market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Exosome Research Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Product (Kits and Reagents, Instruments, Other Products)

5.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)

5.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)

5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

5.2.5. By Company (2022)

5.3. Market Map

5.3.1 By Products

5.3.2 By Indication

5.3.3 By Application

5.3.4 By Region

6. North America Exosome Research Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product (Kits and Reagents, Instruments, Other Products)

6.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)

6.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)

6.2.4. By Country

6.3. North America: Country Analysis

6.3.1. United States Exosome Research Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Product

6.3.1.2.2. By Indication

6.3.1.2.3. By Application

6.3.2. Canada Exosome Research Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Product

6.3.2.2.2. By Indication

6.3.2.2.3. By Application

6.3.3. Mexico Exosome Research Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Product

6.3.3.2.2. By Indication

6.3.3.2.3. By Application

7. Europe Exosome Research Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product (Kits and Reagents, Instruments, Other Products)

7.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)

7.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)

7.2.4. By Country

7.3. Europe: Country Analysis

7.3.1. France Exosome Research Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Product

7.3.1.2.2. By Indication

7.3.1.2.3. By Application

7.3.2. Germany Exosome Research Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Product

7.3.2.2.2. By Indication

7.3.2.2.3. By Application

7.3.3. United Kingdom Exosome Research Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Product

7.3.3.2.2. By Indication

7.3.3.2.3. By Application

7.3.4. Italy Exosome Research Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Product

7.3.4.2.2. By Indication

7.3.4.2.3. By Application

7.3.5. Spain Exosome Research Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Product

7.3.5.2.2. By Indication

7.3.5.2.3. By Application

8. Asia-Pacific Exosome Research Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product (Kits and Reagents, Instruments, Other Products)

8.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)

8.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)

8.2.4. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Exosome Research Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Product

8.3.1.2.2. By Indication

8.3.1.2.3. By Application

8.3.2. India Exosome Research Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Product

8.3.2.2.2. By Indication

8.3.2.2.3. By Application

8.3.3. Japan Exosome Research Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Product

8.3.3.2.2. By Indication

8.3.3.2.3. By Application

8.3.4. South Korea Exosome Research Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Product

8.3.4.2.2. By Indication

8.3.4.2.3. By Application

8.3.5. Australia Exosome Research Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Product

8.3.5.2.2. By Indication

8.3.5.2.3. By Application

9. South America Exosome Research Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Product (Kits and Reagents, Instruments, Other Products)

9.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)

9.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)

9.2.4. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Exosome Research Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Product

9.3.1.2.2. By Indication

9.3.1.2.3. By Application

9.3.2. Argentina Exosome Research Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Product

9.3.2.2.2. By Indication

9.3.2.2.3. By Application

9.3.3. Colombia Exosome Research Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Product

9.3.3.2.2. By Indication

9.3.3.2.3. By Application

10. Middle East and Africa Exosome Research Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Product (Kits and Reagents, Instruments, Other Products)

10.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)

10.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)

10.2.4. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Exosome Research Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Product

10.3.1.2.2. By Indication

10.3.1.2.3. By Application

10.3.2. Saudi Arabia Exosome Research Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Product

10.3.2.2.2. By Indication

10.3.2.2.3. By Application

10.3.3. UAE Exosome Research Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Product

10.3.3.2.2. By Indication

10.3.3.2.3. By Application

11. Market Dynamics

11.1. Drivers

11.1.1 Growing demand for lab automation activities

11.1.2 Growing adoption of lab informatics by biobanks

11.1.3 Growing introduction of technologically advanced software services

11.2. Challenges

11.2.1 Lack of integration standards for laboratory informatics

11.2.2 Stringent Regulations

12. Market Trends & Developments

12.1. Recent Development

12.2. Mergers & Acquisitions

12.3. Product Launches

13. Global Exosome Research Market: SWOT Analysis

14. Porter’s Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Business Overview

15.2. Product Offerings

15.3. Recent Developments

15.4. Financials (As Reported)

15.5. Key Personnel

15.6. SWOT Analysis

15.6.1 Thermo Fisher Scientific.

15.6.2 System Biosciences.

15.6.3 Bio-Techne.

15.6.4 Lonza.

15.6.5 QIAGEN.

15.6.6 ExoDx.

15.6.7 Hitachi Chemical.

15.6.8 Aethlon Medical.

15.6.9 NanoSomiX.

15.6.10 Malvern Panalytical.

15.6.11 Sistemic Scotland Limited.

15.6.12 NX PharmaGen

Strategic Recommendations

Figures and Tables

Frequently asked questions

Which product is expected to dominate the global exosome research market during the forecast period?

The kits and reagents segment is expected to dominate the global exosome research market during the forecast period due to the increase in the need for molecular diagnosis and the surge in R&D activities for the purpose of diagnosis.

What are the major drivers for the global exosome research market?

The increase in demand for drug therapies and the surge in R&D activities in the pharmaceutical and biopharmaceutical fields, stimulated by the potential of exosome technologies as diagnostic and therapeutic tools are used for the treatment of various diseases, are some of the major factors driving the global exosome research market.

Which region is expected to hold the largest share in the global exosome research market during the forecast period?

North America is expected to hold the largest share in the global exosome research market in the coming years due to the rise in the number of studies concerning exosomes.